VA Journal Club: Factor XI Inhibitors and Atrial Fibrillation

Friday, August 7 | 11:00 AM EDT

Zoom

Eric H. Yang (Host)

UCLA Health / Ronald Reagan UCLA Medical Center

Papers

Asundexian versus Apixaban in Patients with Atrial Fibrillation
New England Journal of Medicine · 2024 · Jonathan P. Piccini, Manesh R. Patel
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
New England Journal of Medicine · 2025 · Christian T. Ruff, Siddharth M. Patel

Already on Synapse?

Free for clinicians, fellows, and researchers.